BioSpace News Archive

Business

New Company Debuts with $72 Million to Advance a Novel Class of Targeted Radiopharmaceuticals

Aktis Oncology launched today with significant financing in hand to advance a novel class of targeted radiopharmaceuticals to treat a broad range of solid tumor cancers. The company’s launch was supported by pharma giants including Bristol Myers Squibb and Novartis.

March 18, 2021
·
3 min read
·
Alex Keown
Drug Development

Translate Bio’s mRNA Candidate Fails to Show Benefit in Cystic Fibrosis Trial

Findings from a second interim analysis of a first-in-human Phase I/II clinical trial of Translate Bio’s CF mRNA candidate, MRT5005, show the drug did not significantly improve lung function in patients with CF.

March 18, 2021
·
3 min read
·
Brandon May
Policy

Medical Experts Push Back on AstraZeneca-Oxford Vaccine Worries

More than a dozen countries have suspended deployment of the AstraZeneca-Oxford University vaccine after cases of blood clots were reported.

March 18, 2021
·
4 min read
·
Mark Terry
Policy

HHS Halts Bamlanivimab Distribution in Three States as COVID-19 Variants Spread

The HHS will limit the use of Bamlanivimab antibody treatments developed by Regeneron and Eli Lilly due to concerns the medications are not effective against these new strains.

March 18, 2021
·
3 min read
·
Alex Keown
Business

Gilead and Novo Nordisk Plan Phase IIb Trial of Triple-Combo Therapy for NASH

It will evaluate about 440 patients and the treatments’ effect on liver fibrosis improvement and NASH resolution.

March 18, 2021
·
4 min read
·
Mark Terry
BioCapital

Research Roundup: Myelin and Age-Related Brain Deterioration and More

Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.

March 18, 2021
·
5 min read
·
Mark Terry
Business

Pharma Companies in Deal-Making Mode This Week

Multiple pharmaceutical companies struck large licensing deals with one another this week. Here’s a look.

March 18, 2021
·
4 min read
·
Alex Keown
Business

Immune Regulation’s Rebrand Reflects ‘Revolutionary’ Approach to Autoimmune Diseases

New Orleans-based Revolo Biotherapeutics, formerly known as Immune Regulation, rebranded to reflect its revolutionary scientific approach to dramatically alter the autoimmune and allergic disease treatment landscape.

March 18, 2021
·
4 min read
·
Alex Keown
Business

Anima Biotech and Takeda Enter Collab to Target mRNA Translation with Small Molecules

Anima Biotech’s strategic collaboration with Takeda Pharmaceutical, just announced today, uses its novel platform for discovery of mRNA translation modulators to discover and develop a new class of therapies for neurological diseases.

March 18, 2021
·
5 min read
·
Gail Dutton
Policy

Top Research Scientists Suggest Needle-Free COVID-19 Vaccines Are on the Way

According to an interview with Soumya Swaminathan, the WHO’s chief scientist, the new investigational COVID-19 vaccines rely on alternative technologies and systems of delivery. Some include oral and nasal administration, while others use skin patches.

March 18, 2021
·
3 min read
·
Brandon May